Christopher Barry Wood

Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith.

MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.

MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.

Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014.

Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood.

Navion Pharma Ltd. operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases. The company was founded in 2008 and is headquartered in London, GB.